Sandip K. Datta, MD
Year elected: 2016
Current membership category: Active
Merck Research Laboratories
33 Avenue Louis Pasteur
Boston, MA 02115
United States of America
Phone: 617-992-3243
Email: sandip.datta@merck.com

Biographical statement

Sandip Datta received his M.D. from University of California, San Francisco, and completed his residency in Internal Medicine and fellowship in Infectious Diseases at University of California, San Diego. He trained in the laboratory of Eyal Raz at UCSD, where he was appointed Assistant Professor in 2004. From 2008 to 20017, he was a Clinical Investigator and Head of the Bacterial Pathogenesis Unit in the Laboratory of Clinical Infectious Diseases at NIH/NIAID, where his research focused on host defense against bacteria, with a particular emphasis on the human pathogen Staphylococcus aureus. His laboratory used cellular, animal model, and patient-based studies to investigate how interactions between the host immune system, the pathogen, and the commensal microbiota shape responses to infection and vaccination. In 2017, Dr. Datta joined Merck Research Laboratories (Merck & Co, Inc) in Boston as Prinicpal Scientist and Clinical Director in Translational Pharmacology to guide early clinical development of drugs and vaccines.

Institutional affiliations

Merck & Co. (Primary)
NIH, National Institute of Allergy and Infectious Diseases (Secondary)

Specialties

Infectious Disease
Internal Medicine